Life Healthcare reported a voluntary update for the eleven months to 31 August 2026, and said it remains on track with FY26 guidance. Revenue rose 1.7%, constrained by funder disruptions and negative case mix. Normalised EBITDA increased 5.7%, supported by cost savings and operational efficiencies. PPDs gained 0.2%, while occupancy improved to 69.5%, above 68% guidance.
Click here to read the SENS